Applovin(APP.US) Director Sells US$10.03 Million in Common Stock
Spotlight on AppLovin: Analyzing the Surge in Options Activity
3 Reasons Growth Investors Will Love AppLovin (APP)
AppLovin (APP) Is Up 14.50% in One Week: What You Should Know
Express News | Form 144 | Applovin(APP.US) Director Proposes to Sell 10.02 Million in Common Stocks
US Market Movers & Shakers in November: APP, COIN, MSTR and More
Today's Analyst Rating | Amgen Price Target Raised to $305 by Deutsche Bank, Applovin Price Target Raised to $400 by Jefferies
Piper Sandler Initiates Applovin(APP.US) With Buy Rating, Announces Target Price $400
Piper Sandler Keeps Their Buy Rating on AppLovin (APP)
The Zacks Analyst Blog AppLovin, Cadence Design Systems and Workday
Applovin(APP.US) Officer Sells US$126.48 Million in Common Stock
Express News | Form 144 | Applovin(APP.US) Officer Proposes to Sell 9.69 Million in Common Stocks
Software Stocks & ETFs: Next Big AI Opportunity?
Loop Capital Maintains Applovin(APP.US) With Buy Rating, Maintains Target Price $385
AppLovin Stock Surges 289% in 6 Months: How Should Investors Play It?
Jefferies Maintains Buy on AppLovin, Raises Price Target to $400
Jefferies Maintains Applovin(APP.US) With Buy Rating, Raises Target Price to $400
Analysts Are Bullish on Top Technology Stocks: WNS (WNS), AppLovin (APP)
Investment Opportunities in US Stocks Ahead of Trump's Inauguration
Today's Analyst Rating | UnitedHealth Price Target Raised to $655 by RBC Capital, Citi Upgrades Chevron to Buy